Background The high prevalence of non-specific low back pain and its correlation with the findings in the lumbar multifidus muscles (electromyography activity, morphology and thickness) and good ...
Mainstay Medical Holdings plc has won U.S. FDA approval for its Reactiv8 implantable neurostimulation device. The company is eyeing a commercial launch of the system in early 2021. The FDA approved ...
“This is a totally new way of treating back pain,” said Prentiss Lawson Jr., M.D., an associate professor in the UAB Department of Anesthesiology and Perioperative Medicine and program director of the ...
Both space and ageing can cause atrophy of a "forgotten" muscle.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results